SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl- concentration
© 2024. The Author(s)..
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection disrupts the epithelial barrier and triggers airway inflammation. The envelope (E) protein, a core virulence structural component of coronaviruses, may play a role in this process. Pathogens could interfere with transepithelial Cl- transport via impairment of the cystic fibrosis transmembrane conductance regulator (CFTR), which modulates nuclear factor κB (NF-κB) signaling. However, the pathological effects of SARS-CoV-2 E protein on airway epithelial barrier function, Cl- transport and the robust inflammatory response remain to be elucidated. Here, we have demonstrated that E protein down-regulated the expression of tight junctional proteins, leading to the disruption of the airway epithelial barrier. In addition, E protein triggered the activation of Toll-like receptor (TLR) 2/4 and downstream c-Jun N-terminal kinase (JNK) signaling, resulting in an increased intracellular Cl- concentration ([Cl-]i) via up-regulating phosphodiesterase 4D (PDE4D) expression in airway epithelial cells. This elevated [Cl-]i contributed to the heightened airway inflammation through promoting the phosphorylation of serum/glucocorticoid regulated kinase 1 (SGK1). Moreover, blockade of SGK1 or PDE4 alleviated the robust inflammatory response induced by E protein. Overall, these findings provide novel insights into the pathogenic role of SARS-CoV-2 E protein in airway epithelial damage and the ongoing airway inflammation during SARS-CoV-2 infection.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Signal transduction and targeted therapy - 9(2024), 1 vom: 25. März, Seite 74 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Xu, Jian-Bang [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 27.03.2024 Date Revised 28.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41392-024-01753-z |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370175751 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370175751 | ||
003 | DE-627 | ||
005 | 20240329000950.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240327s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41392-024-01753-z |2 doi | |
028 | 5 | 2 | |a pubmed24n1353.xml |
035 | |a (DE-627)NLM370175751 | ||
035 | |a (NLM)38528022 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Xu, Jian-Bang |e verfasserin |4 aut | |
245 | 1 | 0 | |a SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl- concentration |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.03.2024 | ||
500 | |a Date Revised 28.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection disrupts the epithelial barrier and triggers airway inflammation. The envelope (E) protein, a core virulence structural component of coronaviruses, may play a role in this process. Pathogens could interfere with transepithelial Cl- transport via impairment of the cystic fibrosis transmembrane conductance regulator (CFTR), which modulates nuclear factor κB (NF-κB) signaling. However, the pathological effects of SARS-CoV-2 E protein on airway epithelial barrier function, Cl- transport and the robust inflammatory response remain to be elucidated. Here, we have demonstrated that E protein down-regulated the expression of tight junctional proteins, leading to the disruption of the airway epithelial barrier. In addition, E protein triggered the activation of Toll-like receptor (TLR) 2/4 and downstream c-Jun N-terminal kinase (JNK) signaling, resulting in an increased intracellular Cl- concentration ([Cl-]i) via up-regulating phosphodiesterase 4D (PDE4D) expression in airway epithelial cells. This elevated [Cl-]i contributed to the heightened airway inflammation through promoting the phosphorylation of serum/glucocorticoid regulated kinase 1 (SGK1). Moreover, blockade of SGK1 or PDE4 alleviated the robust inflammatory response induced by E protein. Overall, these findings provide novel insights into the pathogenic role of SARS-CoV-2 E protein in airway epithelial damage and the ongoing airway inflammation during SARS-CoV-2 infection | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Glucocorticoids |2 NLM | |
700 | 1 | |a Guan, Wei-Jie |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yi-Lin |e verfasserin |4 aut | |
700 | 1 | |a Qiu, Zhuo-Er |e verfasserin |4 aut | |
700 | 1 | |a Chen, Lei |e verfasserin |4 aut | |
700 | 1 | |a Hou, Xiao-Chun |e verfasserin |4 aut | |
700 | 1 | |a Yue, Junqing |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Yu-Yun |e verfasserin |4 aut | |
700 | 1 | |a Sheng, Jie |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Lei |e verfasserin |4 aut | |
700 | 1 | |a Zhu, Yun-Xin |e verfasserin |4 aut | |
700 | 1 | |a Sun, Jing |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Jincun |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Wen-Liang |e verfasserin |4 aut | |
700 | 1 | |a Zhong, Nan-Shan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Signal transduction and targeted therapy |d 2016 |g 9(2024), 1 vom: 25. März, Seite 74 |w (DE-627)NLM257871861 |x 2059-3635 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2024 |g number:1 |g day:25 |g month:03 |g pages:74 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41392-024-01753-z |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2024 |e 1 |b 25 |c 03 |h 74 |